FDA — authorised 29 December 1989
- Marketing authorisation holder: BRACCO
- Status: approved
🇺🇸 Rubidium Chloride Rb 82 in United States
FDA authorised Rubidium Chloride Rb 82 on 29 December 1989
Marketing authorisations
FDA — authorised 30 September 2016
- Application: NDA202153
- Marketing authorisation holder: JUBILANT
- Local brand name: RUBY-FILL
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
Rubidium Chloride Rb 82 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Rubidium Chloride Rb 82 approved in United States?
Yes. FDA authorised it on 29 December 1989; FDA authorised it on 30 September 2016.
Who is the marketing authorisation holder for Rubidium Chloride Rb 82 in United States?
BRACCO holds the US marketing authorisation.